TWI331921B - - Google Patents

Download PDF

Info

Publication number
TWI331921B
TWI331921B TW96144911A TW96144911A TWI331921B TW I331921 B TWI331921 B TW I331921B TW 96144911 A TW96144911 A TW 96144911A TW 96144911 A TW96144911 A TW 96144911A TW I331921 B TWI331921 B TW I331921B
Authority
TW
Taiwan
Prior art keywords
red
extract
vine
solvent
chicken
Prior art date
Application number
TW96144911A
Other languages
Chinese (zh)
Other versions
TW200906431A (en
Original Assignee
Food Industry Res & Dev Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Food Industry Res & Dev Inst filed Critical Food Industry Res & Dev Inst
Priority to TW96144911A priority Critical patent/TW200906431A/en
Priority to JP2008183769A priority patent/JP5156515B2/en
Publication of TW200906431A publication Critical patent/TW200906431A/en
Application granted granted Critical
Publication of TWI331921B publication Critical patent/TWI331921B/zh
Priority to US13/098,142 priority patent/US8273388B2/en

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

1331921 九、發明說明: 【發明所屬之技術領域·】 本發明係一種紅雞屎藤萃取物,尤其是—種含有能夠 抑制腸道糖解酵素和肝臟中乙醯辅酶A羧化酵素(acetyh CoA carboxylase,ACC)之活性,並促進肝臟中醯基輔酶A 氡化酵素(AcyhCoA oxidase,ACO)之活性,以改善代謝 症候群的红雞屎藤萃取物。 【先前技術】 美國第5,531,991號專利案揭露一種「利用何首島 (P〇丨ygonum muitin〇rum)萃取物治療血糖過高症的組成物 與方法」,其係一種將何首烏以〇.彳N的氫氧化銨萃取所 得之萃取物,經過葡聚凝膠G_25(sephadex G-25)劃分為 3個組份(fract丨on),而何首物萃取物具有類似增加胰島素 活性的功效以及調節血糖的功能。 而在美國第6,200,569號專利案中揭露一種「增加胰 島素活性的組成物與方法」,其係一種利用何首島 (户〇⑽刪m㈣臟〇_)與傘菌科㈣⑽咖叫的細菌或 銀葉桂(C/卿爪嶋⑺職·re/)所組成的複方水萃*,該複 方水萃物具有增加胰島素活性 不,在庄之功效,並有調節血糖的功 以上兩件美國專利揭係利用何首烏(Ρ·_ 域撕_作為原料,並且以増加姨島素活性的機制來調 朗血糖,目此不具有調節血脂的作用,更不具有改善代樹 症候群的功效。 另外,在EP1 82951 9A1的專利案中一種「用於治療 和’或防止血脂過高症的醫藥組合物以及製造和使用該醫藥 :物的方法」’其係揭露由何首烏山楂丹蔘和山七 的萃製物,按-定比例所組成的複方組合物,該複方組合 物具有調節血脂的功能,然@,此結果僅呈現於人體試: 結果’並未揭露可能的作用機制。 /然而,上述歐洲專利是利用何首烏作為原料,並且必 須搭配其他萃製物所形成的複方組合物材具有調節血脂的 作用’但其並未揭露具有調節▲糖或者改善代謝症候群的 效果。 綜上所述,既有的降血糖或降血脂的組合物皆係利用 一般傳統的何首烏(po/yfif〇仙⑺⑺叻//7〇π 直 中國大陸,而且傳統何首烏的藥用部分在於其:大= 根0 —再者目則市面上只有降血脂或是降血糖等單一功能 的樂物或食品’並無針對代謝症候群發展藥物或食品。然 而,代謝症候群發生的情形越來越普遍,因此本研究即係 要篩選具有抑制腸道糖份的吸收、抑制脂肪酸合成並促進 脂肪酸氧化的植物性原m發出解決代謝症候群的相 關產品。 【發明内容】 本發明人另鐾於目前所利用的何首烏皆為傳統何首 烏’而且僅有單-的降血糖或者降血脂的功能而無任何 有關治療代謝症候群的研究出現,因此經過長時間的研究 1331921 =及不斷的嘗試之後,終於發明出具有改善代謝症候群功 月匕的紅雞屎藤萃取物。 · 二本發明之目的係在於提供一種單獨利用紅雞屎藤(又名 台灣何首烏)的萃取物,使其抑制腸道糖解酵素和肝臟中乙 醯輔酶A羧化酵素(acety丨_c〇A ca「b〇xy丨ase acc)之活 ^^^^(acyl-C〇A oxidase, ACO)之活性,以用於改善代謝症候群的紅㈣藤萃取物。 為達上述目的,本發明係相關於一種用於改善代謝症 候群的紅雞屏、藤萃取物,其係包括以下述方法所製備:提 供新鮮或經乾燥之红料藤植株或局部;以溶劑萃取該紅 雞屎藤植株或局部以獲取溶劑萃取物;濃縮乾燥該溶劑萃 取物;及獲取該紅雞屎藤萃取物。 較佳的是,所提供之紅雞屎藤局部係莖部與根部。 較佳的是,萃取該紅雞屎藤植株或局部的溶劑可為 水、醇類、醇類水溶液以及乙酸乙酯,其中水尚可於升高 的m·度下進行紅雞原藤植株或局部的萃取,其係可將水放 入一般熬煮中藥之藥壺内,直接將紅雞屎藤植株或局部加 溫熬煮;更佳的是該溶劑為濃度在25〜1〇〇wt〇/。的純乙醇或 乙醇水溶液’最佳的乙醇濃度為70~100wt% ;最佳的是, 醇類溶劑係含有鹽酸的酸性酒精。 較佳的是,萃取該紅雞屎藤莖部與根部係使用酸性酒 精,在紅雞屎藤重量與酸性酒精體積約為1:5至彳:2〇的比 例範圍内,於室溫下進行。 本發明係相關於一種用於改善代謝症候群之醫藥組合 1331921 .物,其包括紅雞原藤萃取物及醫,藥上可接受的載劑或賦形 ,齊! ’其中該紅雞原藤萃取物的製備步驟包括:提供新鮮或 之紅雞原藤植株或局部;以溶劑萃取該紅雞原藤植 株或局部以獲取溶劑萃取物;濃縮乾燥該溶劑萃取物;獲 取紅雞原藤萃取物;及將該紅雞原藤萃取物添加醫藥上可 接受的載劑或賦形劑製成醫藥組合物,以作為改善代謝症 候群之用。 φ 較佳的是,所提供之紅料藤局部係莖部與根部。 較佳的是’萃取該紅雞原藤植株或局部的溶劑可為 水、醇類、醇類水溶液以及乙酸乙醋,其中水尚可於升高 • m下進行紅料藤植株或局部的萃取,其係可將水放 λ 中樂之樂壺内’直接將紅雞屎藤植株或局部加 •㈤熬煮,更佳的是該溶劑為濃度在25〜100wt%的純乙醇或 乙醇水溶液’最佳的乙醇濃度為7〇〜⑽赠。;最佳的是, 醇類溶劑係含有鹽酸的酸性酒精。 _ * 是,萃取該紅雞原藤莖部與根㈣使用酸性酒 精,在紅雞#藤重量與酸性酒精體積約為[5至1:扣 例範圍内,於室溫下進行。 、 本^月同時相關於一種適合代謝症候群病人的食品組 口物二其係包括紅雞原藤萃取物,其製備步隸包括:提供 新鮮或經乾燥之紅雞屎藤植 '、 p> 丨,M冷劑年取該紅雞 I 部以獲取溶劑萃取物;濃縮乾燥該溶劑萃取 物,.獲取紅雞原藤萃取物;及製成食品組合物,以作為改 善代謝症候群之用。 " 1331921 較佳的是,所提供之紅雞原.藤局部係莖部與根部。 較佳的是,萃取該紅‘厍蘊 雖妹滕植株或局部的溶劑可為 水、醇類、醇類水溶液以及乙酸乙酿,其中水尚可於升高 的溫度下進行紅㈣藤植株或局部的萃取,其係可將水放 =一般熬煮中藥之藥壺内,直接將紅雞㈣植株或局部加 恤熬煮,更佳的是該溶劑為濃度在25〜觸wt%的純乙醇或 ^醇水溶液,最佳的乙醇濃度為7〇〜i〇〇wt%;最佳的是, 醇類溶劑係含有鹽酸的酸性酒精。 較佳的是,萃取該紅雞屎藤莖部與根部係使用酸性酒 精,在紅雞屎藤重量與酸性酒精體積約為1:5至1:20的比 例範圍内,於室溫下進行。 由於本發明之步驟簡單,且無需特殊的溶劑即可萃取 出有效能的紅雞屎藤萃取物,因此成本低廉,而且針對腸 道中糖解酵素、肝臟中乙醯辅酶A羧化酵素(Acety丨-c〇a1331921 IX. Description of the invention: [Technical field to which the invention pertains] The present invention relates to a red pheasant extract, in particular, a substance capable of inhibiting intestinal glycolytic enzymes and acetylated coenzyme A carboxylate in the liver (acetyh CoA) Carboxylase, ACC), and promotes the activity of AcyhCoA oxidase (ACO) in the liver to improve the metabolic syndrome of red pheasant. [Prior Art] U.S. Patent No. 5,531,991 discloses a "composition and method for treating hyperglycemia using extracts of P〇丨ygonum muitin〇rum", which is a type of Polygonum multiflorum. The extracted extract of ammonium hydroxide is divided into three components (fract丨on) by glucopolymer G_25 (sephadex G-25), and the extract of Heshou has similar effects of increasing insulin activity and regulating blood sugar. The function. In the U.S. Patent No. 6,200,569, a "composition and method for increasing insulin activity" is disclosed, which is a method of using bacteria or silver in Heshou Island (Hou (10), m (four), viscera _) and agaric (4) (10) coffee. Ye Gui (C/Qing Qiong (7) position·re/) composed of compound water extract*, the compound water extract has the effect of increasing insulin activity, the effect of Zhuang, and the regulation of blood sugar. The use of Polygonum multiflorum (Ρ·_ domain tearing _ as a raw material, and to increase the blood sugar by the mechanism of 増 姨 素 素 , , , , , , , , , , , , , 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖 血糖82951 9A1 Patent "A pharmaceutical composition for treating and preventing or preventing hyperlipidemia and a method for producing and using the same" which discloses a extract from Hosho Mountain, Tandan and Shanqi a compound composition consisting of - a proportional composition having a function of regulating blood lipids, and @, the result is only presented in the human body test: the result ' does not reveal a possible mechanism of action. / However, the above-mentioned European patent The use of Polygonum multiflorum as a raw material, and must be combined with other extracts to form a combination of substances to regulate blood lipids 'but it does not reveal the effect of regulating ▲ sugar or improving metabolic syndrome. In summary, the existing decline The composition of blood sugar or blood fat lowering is based on the general traditional Polygonum multiflorum (po/yfif〇(7)(7)叻//7〇π straight to the mainland of China, and the medicinal part of the traditional Polygonum multiflorum lies in it: large = root 0 - again There is only a single-function music or food that lowers blood fat or lowers blood sugar. There is no drug or food for metabolic syndrome. However, the occurrence of metabolic syndrome is more and more common, so this study is to screen the intestines. The phytoplasma that absorbs the sugar, inhibits the synthesis of fatty acids, and promotes the oxidation of fatty acids, and the related products that solve the metabolic syndrome. [Invention] The present inventors are also concerned that the Polygonum multiflorum currently used is a traditional Polygonum multiflorum and only has a single - the function of lowering blood sugar or lowering blood fat without any research on the treatment of metabolic syndrome, so after Time study 1331921 = and after continuous trials, the red chicken vine extract with improved metabolic syndrome has been invented. · The purpose of the second invention is to provide a single use of red chicken vine (also known as Taiwan Polygonum) The extract is such that it inhibits intestinal glycolytic enzymes and the activity of acety-coagulase (acety丨_c〇A ca "b〇xy丨ase acc) in the liver ^^^^(acyl-C〇) The activity of A oxidase (ACO) for improving the metabolic syndrome of red (tetra) vine extract. To achieve the above object, the present invention relates to a red chicken screen and vine extract for improving metabolic syndrome, which includes the following Prepared by the method: providing a fresh or dried red vine plant or part; extracting the red pheasant plant or part by solvent to obtain a solvent extract; concentrating and drying the solvent extract; and obtaining the red chicken vine extract Things. Preferably, the red pheasant is provided with a stem and a root. Preferably, the solvent for extracting the local or partial plant of the red pheasant can be water, an alcohol, an aqueous alcohol solution and ethyl acetate, wherein the water can still be used to carry out the red pheasant plant or local part at an elevated m·degree. The extraction method can directly put the water into the pot of the traditional Chinese medicine for cooking, and directly heat the red chicken or the vine plant or the whole portion; more preferably, the concentration of the solvent is 25~1〇〇wt〇/ . The optimum ethanol concentration of the pure ethanol or aqueous ethanol solution is 70 to 100% by weight; most preferably, the alcohol solvent is an acidic alcohol containing hydrochloric acid. Preferably, the extract of the red pheasant vine stem and the root system using acidic alcohol, and the ratio of the weight of the red pheasant and the acid alcohol is about 1:5 to 彳:2 ,, at room temperature. . The present invention relates to a pharmaceutical combination 1331921 for improving metabolic syndrome, which comprises red chicken raw vine extract and medically, pharmaceutically acceptable carrier or shaping, Qi! The preparation step of the red chicken raw vine extract comprises: providing fresh or red chicken raw vine plants or parts; extracting the red chicken raw vine plants or parts by solvent to obtain a solvent extract; concentrating and drying the solvent extract; obtaining red chicken An original rattan extract; and the red chicken raw vine extract is added with a pharmaceutically acceptable carrier or excipient to prepare a pharmaceutical composition for use in improving metabolic syndrome. Preferably, φ is provided with a stem portion and a root portion of the red vine. Preferably, the solvent for extracting the red vine or the partial vine is water, an alcohol, an aqueous alcohol solution and ethyl acetate, wherein the water can still be extracted or partially extracted by the red vine. The system can put the water into the _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Good ethanol concentration is 7〇~(10) gift. Most preferably, the alcohol solvent is an acidic alcohol containing hydrochloric acid. _ * Yes, extract the red stalk from the original stem and root (4) using acid alcohol, in the red chicken # vine weight and acid alcohol volume is about [5 to 1: deduction range, at room temperature. The present month is also related to a food group suitable for patients with metabolic syndrome. The second group includes red chicken raw vine extract, and the preparation steps include: providing fresh or dried red chicken 屎藤植', p> The M cold agent takes the red chicken I part to obtain a solvent extract; the solvent extract is concentrated and dried, and the red chicken raw vine extract is obtained; and the food composition is prepared to improve the metabolic syndrome. " 1331921 Preferably, the stems and roots of the red broiler vines are provided. Preferably, the extraction of the red '厍 虽 虽 虽 妹 妹 妹 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或 或Partial extraction, which can be used to put water into the pot of the traditional Chinese medicine, and directly cook the red chicken (four) plants or parts, preferably the solvent is pure ethanol with a concentration of 25~wt%. Or an aqueous alcohol solution, the optimum ethanol concentration is 7〇~i〇〇wt%; optimally, the alcohol solvent is an acidic alcohol containing hydrochloric acid. Preferably, the stems and roots of the red pheasant are extracted using acid alcohol, and are carried out at room temperature within a ratio of the weight of the red pheasant and the acid alcohol volume of about 1:5 to 1:20. Since the steps of the present invention are simple, and the effective energy of the red pheasant extract can be extracted without special solvent, the cost is low, and the glycolytic enzyme in the intestine and the acetaminophen coenzyme A carboxylate in the liver (Acety丨) -c〇a

Ca「b〇Xylase,ACC)進行實驗後,證實確有抑制的效果並 且能夠促進肝臟中醯基辅酶六氧化酵素(Acy|_c〇A 〇xjdase, ACO>的活性,因此,本發明僅需利用單—的紅雞屎藤萃取 物,即可同時達到調解血脂並調節血糖的功能,並具有改 善代謝症候群的功效。 【實施方式】 請參看第一圖所示,本發明係相關於一種用於改善代 謝症候群的紅雞屎藤萃取物,其係以下述方法所製備,其 包括提供新鮮或經乾燥之紅雞屎藤植株或局部(a);以溶劑 萃取該紅雞屎藤植株或局部以獲取溶劑萃取物(b);濃縮乾 921 知該浴劑萃取物(C);以及獲取 接 該紅雞屎藤萃取物(d)。之 含該紅雞藤萃取物的食品組的合物⑷或包 本㈣係首先利用溶劑對新鮮或經乾燥之红難摩藤植 株進行卒取,利用溶劑將紅雞屏 d 雖乐勝中所含可溶於溶劑内的 活性成分加以溶出,並進一步利 〜用該可溶於溶劑内的活性 成分,處理腸道糖解酵素及肝M + 叮械中的酵素,發現其能調節 血糖與血脂調控關鍵酵素活性。在本發明之具體實施例 中,可以發現利用該可溶於溶劑内的活性成分具有抑制腸 道糖解酵素、肝臟乙酿輔酶A緩化酵素之活性,並能促進 肝細胞醯基輔酶A氧化酵素之活性。因此,本發明所獲取 之紅雞屎藤萃取物可進-步配合醫藥上可接受的載劑或賦 形劑’以製成治療代謝症候群之醫藥組合物或相關保健食 品等。 本發明所指之『紅雞屎藤』又稱台灣何首烏(Tajwan Tuber Fleeceflower) ’其原產地為台灣,為台灣固有種, 不具有明顯的塊根’為傳統何首烏的變種,亦為中藥藥材 的一種,常見於台灣全島中低海拔山區,多生長於路邊及 林緣,但目前並未有人將台灣何首烏的根莖部替代傳統何 首烏來使用。紅雞屎藤係屬於黎屬⑺)、蓼科 (Po/ygonaceae) ’ 其學名可為 po/ygo⑽m mw/i/"〇a7mAfter the experiment of Ca "b〇Xylase, ACC", it was confirmed that it had an inhibitory effect and promoted the activity of the 醯Kymase hexaoxidase (Acy|_c〇A 〇xjdase, ACO> in the liver. Therefore, the present invention only needs to utilize The single-red chicken vine extract can simultaneously achieve the function of regulating blood lipids and regulating blood sugar, and has the effect of improving metabolic syndrome. [Embodiment] Referring to the first figure, the present invention relates to one for An improved red locust extract of the metabolic syndrome, which is prepared by the following method, which comprises providing fresh or dried red pheasant plants or parts (a); extracting the red pheasant plant or part by solvent Obtaining a solvent extract (b); concentrating dry 921 to know the bath extract (C); and obtaining a food group containing the red chicken vine extract (d) Or the package (4) is to use the solvent to draw the fresh or dried red vine plant, and use the solvent to dissolve the active ingredient in the solvent contained in the red chicken, and further benefit ~ Use this soluble The active ingredient in the solvent, the enzyme in the intestinal glycolytic enzyme and the liver M + machinery, which is found to regulate blood sugar and blood lipid regulation key enzyme activity. In a specific embodiment of the present invention, it can be found that the use of the soluble The active ingredient in the solvent has the activity of inhibiting intestinal glycolytic enzyme, liver coenzyme A-lowering enzyme, and can promote the activity of hepatocyte 醯Kease A oxidase. Therefore, the red chicken vine extract obtained by the invention The pharmaceutical composition or the related health food for treating metabolic syndrome can be prepared by further mixing with a pharmaceutically acceptable carrier or excipient. The "Red Chicken and Rattan", also referred to as Taiwan Polygonum multiflorum (also referred to as Taiwanese Polygonum) Tajwan Tuber Fleeceflower) 'The origin of Taiwan is Taiwan, which is an intrinsic species of Taiwan. It does not have obvious roots. It is a variant of traditional Polygonum multiflorum. It is also a kind of traditional Chinese medicine. It is common in the middle and low altitude mountains of Taiwan. It grows on the roadside and Lin Yuan, but no one has used the roots of Polygonum multiflorum in Taiwan to replace the traditional Polygonum multiflorum. The red pheasant belongs to the genus (7)) and the genus Po/ygonaceae. ’ The scientific name can be po/ygo(10)m mw/i/"〇a7m

Thunb· Ex murray var. hypoleucum (Ohwi) Liu, Ying & Lai 、 Pleuropterus hypoleucus multiflorum, Polygonum hypo/euctym Ohwi and Po/ygonum mty/i/77〇rum Thunb· var· 1331921 謂(〇hWi) Liu,Ying & Lai,其根與藤(莖)的部分 能夠鎮咳、怯風、怯痰’治療感f咳嗷風濕等;而葉部; 以治療感冒、外敷刀傷等。 本發明所指之『代謝症候群(metab〇||c syndr〇r^) 意指姨島素阻抗症候群(ins_㈣咖…。叫,i 係心因肥胖所產生的第二型糖尿病患者所併發高血屋、言 灰月日等症狀。而膜島音阳p 叩胰島京阻抗性(丨nsu丨m resistanc =Γ:Γ的共同致病轉機’其係可藉由抑制: 酿輔…化酵素、促進_基輔 酵素、控制血糖、血脂濃度而被改善。 雞厚==指之『紅雞原藤萃取物』意指利用溶劑對紅 性成藤植=進行萃取’以獲取紅雞原藤内可溶於溶劑的活 ^等該溶劑可為水、醇類如乙醇、醇類水溶液以及乙 序=,乙醇較佳係為酸性酒精。在本發明中,該紅雞 可為新鮮或經乾燥之全株植株 明較佳係—:=::Γ㈣藤根部等;在本發 滚乾係,減壓濃縮法、冷 燥方法。 ' :具有通常知識者所知的濃縮乾 物為指之『醫藥上可接受的載劑』,若醫藥組合 作用位置前二則载劑係能保護該醫藥级合物在尚未到達 促進藥物的釋Γ化系統的分解’而失去效用,和,或能夠 J叼釋敌以及效果。 本發明所指之f醫 藥物的均勻性、穩〜接戈的賦形劑』係為了增加 如M "疋與減少藥物的刺激性'不良氣味等, 如糖醇、澱粉或Α仙认丄 劑。. ’、;本領域具有通常知識者所知的賦形 本發明之紅雞届藤装 候群的# % ,其係可製作成改善代謝症 恢群的醫樂組合物, 口服給予形式丄 不同的形式,包括但不限於 、.θ人 / 4括早獨新穎形式的紅雞原藤萃取物或 = 接受之載劑,口服給予的形式可選自包括 由錠劑、粉末、懸浮液、 匕秸 丄、 扎厲液膠囊、顆粒、片劑、藥 、液體、酒精劑和含藥糖漿所組成之族群中。 ’、 以下實施例係為了具體說明本發明之技術手段,並且 將本發明之紅雞原藤萃取物與特定酵素作用後進行活性分 析。 貫施例1_紅雞屎藤萃取物的製備 醆性酒精萃敌躲: 將紅雞原藤以磨碎機研磨後,以酸性酒精(添 U鹽酸(HC丨))萃取,紅雞原藤之重量與酸性酒精= 的比例約為1 : 8(W/V=1/8),將其放置室溫中 τ置或j;2 "Sf 用1000轉(rpm)的速度震盪萃取。 72小時後’以紗布做初步的過濾,所 J您夜再以每 分鐘6000轉(rpm)的速率離心15分鐘,& μ a 上續液濃縮乾 燥成為酸性酒精萃取物,其萃取率約為6.9% 。 再將該萃取物複溶,使其濃度為5〇mg/m丨。Thunb· Ex murray var. hypoleucum (Ohwi) Liu, Ying & Lai, Pleuropterus hypoleucus multiflorum, Polygonum hypo/euctym Ohwi and Po/ygonum mty/i/77〇rum Thunb· var· 1331921 (〇hWi) Liu,Ying & Lai, the root and the vine (stem) part can cough, hurricane, phlegm 'treatment feeling c cough rheumatism, etc.; and the leaves; to treat colds, external wounds and so on. The term "metabolic syndrome" (metb〇||c syndr〇r^) means 姨 ( 阻抗 impedance syndrome (ins_(四) 咖...., i is a type 2 diabetes patient with obesity and high blood Houses, words, gray days and other symptoms. And the membrane island Yin Yang p 叩 islet resistance (丨nsu丨m resistanc = Γ: 共同 common pathogenic turnaround) can be suppressed by: auxiliaries... _ Kiev enzymes, control of blood sugar, blood lipid concentration and improved. Chicken thickness == refers to the "red chicken raw vine extract" means the use of solvents for red vines into the plant = extract 'to obtain red chicken vines soluble in solvents The solvent may be water, an alcohol such as ethanol, an aqueous alcohol solution, and a subsequence =, and the ethanol is preferably an acidic alcohol. In the present invention, the red chicken may be a fresh or dried whole plant. Preferably, the system is: -=:: Γ (4) vine roots, etc.; in the present hair drying system, decompression concentration method, cold drying method. ' : Concentrated dry matter known to those who are generally known as "medically acceptable load" Agent, if the pharmaceutical combination is in the first two positions, the carrier can protect the pharmaceutical conjugate. It does not reach the decomposition of the drug release system, and it loses its effectiveness, and, or can release the enemy and the effect. The uniformity of the medicine of the present invention, the stable and the durable excipients are Adding such as M " 疋 and reducing the irritation of the drug 'bad odor, etc., such as sugar alcohol, starch or 丄 丄 丄 。 。 。 。 。 。 。 。 。 。 赋 糖 赋 赋 赋 赋 本 本 本 本 本 本 本The vinegar group's #%, which can be made into a therapeutic composition that improves the recovery of metabolic syndrome, is given orally in different forms, including but not limited to, θ people / 4 years old alone in the form of red chicken Oral vine extract or = acceptable carrier, the form of oral administration may be selected from the group consisting of a tablet, a powder, a suspension, a sputum, a sputum capsule, a granule, a tablet, a drug, a liquid, an alcohol, and a medicated drug. In the group consisting of syrups, 'The following examples are for the purpose of specifically explaining the technical means of the present invention, and the activity of the red hen extract of the present invention is reacted with a specific enzyme to carry out an activity analysis. Preparation of extracts Enemy enemies: After grinding the red chicken raw vines with a grinder, extract with acidic alcohol (addition of U hydrochloric acid (HC丨)), the ratio of the weight of red hens to the acid alcohol = about 1: 8 (W / V = 1/8), place it at room temperature for τ or j; 2 "Sf is oscillated at 1000 rpm. After 72 hours, use gauze for preliminary filtration. Centrifuge at 6000 rpm for 15 minutes, concentrate on & μ a and concentrate to dry to an acidic alcohol extract with an extraction rate of about 6.9%. Re-dissolve the extract to a concentration of 5 〇 mg/ m丨.

12 1331921 熱水苯敗物 將紅雞屎藤放入中藥壺熬煮約兩個小時,紅雞屎藤之 重量與水之體積比約為1:20 (W/V= 1 /20) ’再以紗布過濾, 該濾液以冷凍乾燥的方式得到熱水萃取物,其萃取率約為 9.2% 〇 再將該萃取物複溶,使其濃度與酸性酒精萃取物一樣 為50 mg/ml,以進行下述實驗。 實施例2.紅雞屎藤萃取物抑制α -葡萄糖苷酶(〇:- glucosidase) 以對硝基苯-a -D-葡萄糖苦(p-nitrophenyl a -D-glucoside,pNP-G)受質分析法進行抑制葡萄糖苷酶活 性的分析《其方法係包括: 1. 首先以磷酸緩衝溶液(1 OOmM,pH 7.0)配置1 U/ml 的 〇:葡萄糖苷酶(EC3.2.1.20, G5003, Sigma-Aldrich Co·, USA)溶液以及5x10_3M對硝基苯· α _D_。比喃葡糖苷(p_ nitrophenyl a -D-glucopyranoside.pNP-G, Sigma-Aldrich12 1331921 Hot water benzene loser Put the red chicken vine into the Chinese medicine pot and cook for about two hours. The ratio of the weight of the red chicken vine to the water is about 1:20 (W/V = 1 /20) ' Filtered with gauze, the filtrate was lyophilized to obtain a hot water extract with an extraction rate of about 9.2%. The extract was reconstituted to a concentration of 50 mg/ml as the acidic alcohol extract. The following experiment. Example 2. Inhibition of α-glucosidase by P. sinensis extracts p-nitrophenyl a -D-glucoside (pNP-G) Analytical method for analysis of inhibition of glucosidase activity. The methods include: 1. Firstly, 1 U/ml of glucoside: glucosidase (EC 3.2.1.20, G5003, configured with phosphate buffer solution (100 mM, pH 7.0). Sigma-Aldrich Co., USA) solution and 5 x 10_3M p-nitrobenzene·α _D_. P-nitrophenyl a -D-glucopyranoside.pNP-G, Sigma-Aldrich

Co·,USA)受質溶液備用。 2. 隨後於96孔盤之每一孔洞,依序加入4〇微升(^丨) 的填酸緩衝溶液(0.4 M,pH 7.0)、1〇微升("丨)的α -葡萄糖 苷酶溶液,以及不同稀釋度之紅雞屎藤萃取物5〇微升(/y|), 再加入去離子水至170微升(川)。 3. 讓培養箱在37°C的環境中預熱5分鐘後,加入3〇 微升⑺丨)已經預熱的受質溶液,經充分震盪混合後,於37 13 °c的環境下作用10分鐘。 , 4:再以波長4〇5奈米(nm)的光度分析儀贿^… k C〇·,USA〉紀錄前後的吸光值,並用ic50表示 抑制50%之。·葡萄糖苷酶活性所需的濃度。 靖參看表1,其係顯示以酸性酒精萃取物以及熱水萃 取物所得到的結果: 表1. 酸性酒精萃 取物#1 酸性酒精萃 取物#2 熱水萃取物 IC5。(萃取物#Q/ml) 5·5±0·5 6.5±0.7 17.1±0.4 精由表1可以得知紅雞屎藤之酸性酒精和熱水萃取物 對於心葡萄糖普酶之活性皆有抑制的效果,其中== 酒精萃取物所得的效果為佳。 實施例3.紅雞屎藤萃取物抑制不同糖解酵素活性 分析 μ 利用大鼠腸道酵素粗萃液(rat jntestina丨咖嶋 powder, Sigma Chemical Co., St. Louis, 的來源’給予不同糖類受質(麥芽糖、薦糖和殿粉),以測 试酸性酒精紅料料取液對於*同糖解酵素活性的抑制 作用。 請參看表2,其係顯示利用酸性酒精紅雞原藤萃取液 14 1331921 對於不同糖解酵素活性的抑制情形,其亦使用丨c5〇來表示 活性抑制的情形: 表2. -----_ ICS0(萃取物 mg/ml) 解酵辛 澱粉糖解酵素 蔗糖糖解酵素 酸性酒精 萃取物 ----- V吓}S*T Jjs 0.6 —1 -^ 1.9 3.1 由上述表2顯示,酸性酒精萃取物對於麥芽糖糖解酵 素(maltase) ' ;知粉糖解酵素(^ _arny|ase)以及蔗糖糖解酵 素(sucrase)均有抑制的效果,而且抑制強度為麥 芽糖糖解 酵素 >澱粉糖解酵素 >蔗糖糖解酵素。 貫施例4.紅雞屎藤脂溶性萃取物的製備 將紅雞屎藤以磨碎機研磨後’以濃度50wt%的甲醇水 ♦液萃取’紅雞屎藤之重量與50wt%的曱醇水溶液之體積 比例為1 : i〇(w/v=i/i〇),在室溫令震盪萃取24小時後 以不織布過濾,所得之濾液加入等體積之乙酸乙酯(ethy丨 acetate)/水,搖動混合後進行液·液萃取取上層的乙酸乙 酯層,再加入與乙酸乙酯等體積之5wt%碳酸氫鈉(s〇diumCo·, USA) The solution was taken up. 2. Then add 4 μL of acid buffer solution (0.4 M, pH 7.0) and 1 μL ("丨) of α-glucoside in each well of a 96-well plate. The enzyme solution, as well as different dilutions of the red chicken vine extract 5 〇 microliters (/y|), then add deionized water to 170 microliters (Chuan). 3. Allow the incubator to warm up for 5 minutes at 37 ° C, then add 3 μl of microliter (7) 丨) preheated substrate, mix thoroughly and shake, and apply at 37 13 °c. minute. 4: The photometric analyzer with a wavelength of 4〇5 nm (nm) bribes... k C〇·, USA> The absorbance value before and after the record, and the suppression of 50% by ic50. The concentration required for glucosidase activity. See Table 1, which shows the results obtained with acidic alcohol extract and hot water extract: Table 1. Acidic alcohol extract #1 Acidic alcohol extract #2 Hot water extract IC5. (Extract #Q/ml) 5·5±0·5 6.5±0.7 17.1±0.4 Fine It can be seen from Table 1 that the acidic alcohol and hot water extracts of the red pheasant are inhibited by the activity of the heart glucosidase. The effect of the == alcohol extract is better. Example 3. Inhibition of different glycolytic enzyme activities by Red Chicken and Rattan extracts μ Different sugars were administered using a crude extract of rat intestinal enzyme (rat jntestina, curry powder, Sigma Chemical Co., St. Louis, source). Acceptance (maltose, recommended sugar and house powder) to test the inhibitory effect of acid alcohol red material on the activity of *glycolysis enzyme. Please refer to Table 2, which shows the use of acid alcohol red chicken raw vine extract 14 1331921 For the inhibition of different glycolytic enzyme activities, it also uses 丨c5〇 to indicate the inhibition of activity: Table 2. -----_ ICS0 (extract mg/ml) lysing octyl starch lysin sucrose Decomposing Acidic Alcohol Extract----- V Scary}S*T Jjs 0.6 —1 -^ 1.9 3.1 As shown in Table 2 above, the acidic alcohol extract for maltose is a maltase '; Both (^ _arny|ase) and sucrose saccharide (sucrase) have an inhibitory effect, and the inhibitory strength is maltose lyase [starch sugar lyase] sucrose saccharolytic enzyme. Example 4. Red chicken vine Preparation of fat-soluble extracts After grinding by the attritor, the volume ratio of the weight of 'Red Chicken vine' and the 50% by weight aqueous solution of decyl alcohol extracted by the concentration of 50% by weight of methanol water is 1: i〇(w/v=i/i〇). After shaking for 24 hours at room temperature, it was filtered through a non-woven fabric, and the obtained filtrate was added with an equal volume of ethyl acetate (ethy丨acetate)/water, and the mixture was shaken and mixed, and then subjected to liquid-liquid extraction to obtain an ethyl acetate layer of the upper layer, followed by addition of acetic acid. Ethyl acetate equivalent volume of 5wt% sodium bicarbonate (s〇dium

Bicarbonate,NaHC〇3)搖動混合,再去除碳酸氫鈉層,以 洗去游離脂肪酸,接著再濃縮乾燥乙酸乙酯層後,即可得 到所要的脂溶性萃取物,萃取率約為〇 91%。Bicarbonate, NaHC〇3) was shaken and mixed, and the sodium bicarbonate layer was removed to wash away the free fatty acid, followed by concentration and drying of the ethyl acetate layer to obtain the desired fat-soluble extract, and the extraction ratio was about 91%.

15 1331921 該脂溶性萃取物以二曱基亞砜(Dimethyl Sulfoxide, DMSO)複溶,使其濃度為i(jmg/ml。 實施例5.以紅雞屎藤酸性酒精萃取物及脂溶性萃取 物抑制乙醢輔酶A敌化酵素(Acety卜CoA carboxylase, ACC) 之活性分析 乙醯輔酶A羧化酵素(ACC)是脂肪酸合成的關鍵酵 素’其產物丙二醯基輔酶A (malony卜CoA)係脂肪酸合成 酵素(fatty acid synthase,FAS)之受質,且是肉酸素棕櫚 酿轉移酶(carnitin palmitoyl CoA transferase, CPT)的抑 制劑’因此抑制ACC不但可以抑制内生性脂質合成,也 可加速粒線體内脂肪酸的氧化。 自鼠肝純化ACC並進行測試,其步驟係參考Tanabe 等人的方法(Tanabe T.,Nakanishi,S.,Hashimoto T·, Ogiwara, H., Nikawa J., Numa S. 1981. Acetyl-CoA carboxylase from rat liver, Meth. Enzymol. 71(pt C): 5- 16)。所得的結果如表3 : 表3· 抑制ACC活性百分比(%) 酸性酒精萃取物 (0.05ma/mjj_ 61.27 + 5.4 踔溶,(〇 〇5mg/ml) 45.99 + 11.9 16 I3W丄 由上述表3可看出,红雞斤_ 麻“ ·雞屎勝之酸性酒精及脂溶性萃 取物音具有良好之ACC抑制 邶刺活性。再取酸性酒精萃取物 進订丨〇5〇量測。請來看第-R _ 心 有弟一圖所不,其為紅雞原藤酸性酒 精年取物之濃度以及抑制效果的線性變化,由此圖可得知 紅1^滕㈣_萃取物達到抑㈣50%之ACC活性所需 濃度(IC50)為 0.Q4 mg/ml。 實鉍例6.紅雞屎藤酸性酒精萃取物促進醯基輔酶a 氧化酵素(Acyl-CoA oxidase,ACO)的活性分析 醯基輔酶A氧化酵素(AC0)為脂肪酸万氧化作用的關 鍵酵素,亦是過氧化物酶體增殖物激活受體σ (ppARcy)的 典型下游基因,可做為脂肪酸氧化代謝活性的指標。 本項分析是以適當密度接種H4IIEC3肝細胞於12孔 盤中’待队附後’更換為含有不同濃度之已知能促進AC〇 表現之氣苯丁酯(C|0fibrate)或彳〇〇微升/毫升(/y|/m丨)之紅雞 原藤酸性酒精萃取物,培養適當時間,吸去培養液後收集 細胞’針對AC0進行活性測試。 AC〇活性測試係採用smal丨等學者在研究期刊(Small GM. Burdett K. ConNock MJ. 1985. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. B/oc/7em/ca/ Jot;厂 na/· 227:205-210.)中的方法。 請參看第三圖所示,其中第三(A)圖係表示利用不同濃度 (100//M、500//M ' ΙΟΟΟρΜ)之氣笨丁酯在不同時間(48及 72小時)作用下所能促進ACO活性的程度;而第三(Β)圖 17 1331921 • 係表示利用1〇〇W/ml之紅雞屎藤酸性酒精萃取物處理48 . 小時後之ACO活性增加倍數。 ) 實施例7.紅雞屎藤酸性酒精萃取物對於高脂誘發代 謝症候群C57BL/6J小鼠的影響 C57BL/6J小鼠先以含30%(g/g)之奶油的高脂飼料餵 養八週,使出現肥胖、高血脂 '高胰島素血症等代謝症候 群症狀。將此出現代謝症候群症狀之小鼠任意分為兩組, 一組給予添加有3%(g/g)之紅雞屎藤酸性酒精萃取物的高 脂飼料(相當於小鼠體重每公斤給予1 5〇〇毫克之紅雞庫藤 酸性酒精萃取物(1500mg/kg body weight))(HF + No.1l), :另一組維持高脂飼料為對照組(HF)。另有正常飼料對照組 * (LF)。經五週餵食後’進行口服葡萄糖耐受性試驗(oral glucose tolerance test,0GTT),其結果如表四所示。之 後犧牲小鼠’其最終體重以及血液生化分析結果如表五所 示。 表4.第5週口服葡萄糖耐受性測試時,各組小鼠血 糖之變化15 1331921 The fat-soluble extract is reconstituted with Dimethyl Sulfoxide (DMSO) to a concentration of i (jmg/ml. Example 5. Acidic alcohol extract and fat-soluble extract of Red Chicken Activity Analysis of Acety CoA Carboxylase (ACC) is a key enzyme in the synthesis of fatty acids. The product is a malonium-based enzyme A (malony). It is a receptor for fatty acid synthase (FAS) and is an inhibitor of carnitin palmitoyl CoA transferase (CPT). Therefore, inhibition of ACC not only inhibits endogenous lipid synthesis, but also accelerates the grain line. Oxidation of fatty acids in the body. ACC was purified from rat liver and tested by the method of Tanabe et al. (Tanabe T., Nakanishi, S., Hashimoto T., Ogiwara, H., Nikawa J., Numa S. 1981. Acetyl-CoA carboxylase from rat liver, Meth. Enzymol. 71(pt C): 5- 16). The results obtained are shown in Table 3: Table 3. Percentage of inhibition of ACC activity (%) Acidic alcohol extract (0.05ma/ Mjj_ 61.27 + 5.4 踔 dissolve, (〇 〇5mg/ml) 45.99 + 11.9 16 I3W丄 As can be seen from the above Table 3, the red chicken jin _ hemp · · chicken 屎 之 acid alcohol and fat-soluble extract sound has a good ACC inhibition sting activity. Then take acid alcohol extraction The quantity is measured by 丨〇5〇. Please look at the first-R _ heart and the younger one. It is the linear change of the concentration of the acid alcohol in the red vine and the inhibition effect. Red 1 ^ Teng (4) _ extract reached (four) 50% of the ACC activity required concentration (IC50) was 0. Q4 mg / ml. Example 6. Red chicken vine vine acidic alcohol extract promote 醯 Kiev enzyme a oxidase ( Activity analysis of Acyl-CoA oxidase (ACO) 醯Kyivase A oxidase (AC0) is the key enzyme for the oxidation of fatty acids, and is also a typical downstream gene of peroxisome proliferator-activated receptor σ (ppARcy). As an indicator of the oxidative metabolic activity of fatty acids. This analysis is to inoculate H4IIEC3 hepatocytes in appropriate density in a 12-well plate, and replace them with pentylene ketone (C) which is known to promote AC 〇 performance. |0fibrate) or 彳〇〇 升/ml (/y|/m丨) of red chicken The original vine acidic alcohol extract was cultured for a suitable period of time, and the cells were collected after aspirating the culture solution. The AC〇 activity test was conducted by scholars such as smal丨 (Small GM. Burdett K. ConNock MJ. 1985. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. B/oc/7em/ca/ Jot; factory na/· Method in 227: 205-210.). Please refer to the third figure, where the third (A) diagram shows the use of different concentrations (100//M, 500//M ' ΙΟΟΟρΜ) of gas butyl acrylate at different times (48 and 72 hours) The degree of ACO activity can be promoted; and the third (Β) Figure 17 1331921 • indicates the increase in ACO activity after 48 hours of treatment with 1 〇〇W/ml of red chicken vine vine acidic alcohol extract. Example 7. Effect of red chicken vine vine acidic alcohol extract on high fat-induced metabolic syndrome C57BL/6J mice C57BL/6J mice were first fed with high fat diet containing 30% (g/g) cream for eight weeks. To cause symptoms of metabolic syndrome such as obesity, hyperlipidemia and hyperinsulinemia. The mice with symptoms of metabolic syndrome were randomly divided into two groups, and one group was given a high-fat diet supplemented with 3% (g/g) of red chicken vine vine acidic alcohol extract (equivalent to 1 kg per kg of body weight). 5 mg of red chicken vine alcoholic alcohol extract (1500 mg/kg body weight) (HF + No.1l), another group maintained high fat diet as control group (HF). There is also a normal feed control group * (LF). The oral glucose tolerance test (0GTT) was performed after five weeks of feeding, and the results are shown in Table 4. Subsequent sacrifice of the mouse's final body weight and blood biochemical analysis results are shown in Table 5. Table 4. Changes in blood glucose in mice of each group at the 5th week of oral glucose tolerance test

血糖(mmol/L) AUC^Omin Omin 30min 60min 90min 1 20min (mmol*min/L) LF(n = 6.1±1. 10.37土 9.97±1· 8·75±1. 8.56±1 656.3±93.3 a 14) 32a 1.45 a 25 a 52 a 55 a HF(n = 8·76± 12·27± 12·16± 12·25± 13.74士 961.2±76.3CBlood glucose (mmol/L) AUC^Omin Omin 30min 60min 90min 1 20min (mmol*min/L) LF (n = 6.1±1. 10.37 soil 9.97±1·8·75±1. 8.56±1 656.3±93.3 a 14 32a 1.45 a 25 a 52 a 55 a HF(n = 8·76± 12·27± 12·16± 12·25± 13.74±961.2±76.3C

18 丄 6〜7) 2.78 b HF + N 0.1 1 (η =6〜7) 7.6±1. 27a18 丄 6~7) 2.78 b HF + N 0.1 1 (η = 6~7) 7.6±1. 27a

、·口果以千均值土標準偏 是值(SD)表不。上標不同字母 代表有顯著差異性,P<〇 〇5。 — ·’"員不,’·里五週供以紅雞屎藤酸性酒精萃取物,可 顯著降低高脂誘發代謝症候# C57bl/6j小鼠禁食血糖(〇 麵),並且使其在口服葡萄糖耐受性測試之60及90分鐘 糖以及2小時血糖曲線下面積(a「ea unde「叫口㊀,auc) 月顯地較间知對照組者為低。顯示紅雞屎藤酸性酒精萃取 物不僅可以降低禁食血糖,並可改善葡萄糖耐受能力。 表5.飯食五週紅雞屎藤酸性酒精萃取物對於高脂誘 戈—气C57BL/6J小鼠體重及血清生理指標的影響 最終 體重 血清三 酸甘油 酯 (Serum TG) 清總 膽固醇 (Serum TC) 血清胰 島 素 Serum insulin 非酯化 脂肪酸 (NEFA) 痩 素 (Leptin ) ώλΙ (mol/ml) (mmol/l) fng/ml) (mmol/l) (ng/ml) LF(n = 26.2 + 0.99土 2.62土 0.39± 1.27± 467土 14) 1.2C 0.23b 0.43° 0.11b 0.16a 1557° 1331921· The fruit is measured by the mean value (SD). The superscripts with different letters represent significant differences, P<〇 〇5. — ·'"Not, '······················································································· The 60- and 90-minute sugars of the oral glucose tolerance test and the area under the 2-hour blood glucose curve (a "ea unde" called a one, auc) were significantly lower than those of the control group. The extract can not only reduce fasting blood sugar, but also improve glucose tolerance. Table 5. Effect of five-week red chicken vine vine acidic alcohol extract on body weight and serum physiological indexes of high fat yang-qi C57BL/6J mice Final weight serum triglyceride (Serum TG) serum total cholesterol (Serum TC) serum insulin Serum insulin non-esterified fatty acid (NEFA) alizarin (Leptin) ώλΙ (mol/ml) (mmol/l) fng/ml) ( Mmmol/l) (ng/ml) LF (n = 26.2 + 0.99 soil 2.62 soil 0.39 ± 1.27 ± 467 soil 14) 1.2C 0.23b 0.43° 0.11b 0.16a 1557° 1331921

HF(n = 37·〇± 1.38土 4.68土 0.599土 1.63± 5911± 1.8a 0.18a 0‘21a 0.2a 0.45a 1623a hf+n 〇·11(η 35.1± 1.14土 3.69± 0.462± 1.28士 4204± =6〜7、 3.2b 0.32b 1,08b 0.2b 0_25a 2209b 所顯示之數值為平均值±標準偏差值(SD)。 經統計分析’以P值(p_va|ue)<〇 〇5為基準。 上標a、b、c代表有顯著差異性。 表5顯示’給予1500mg/kg body weight之紅雞屎藤 酸性酒精萃取物可以顯著地降低因高脂飲食所引起的高膽 固醇、高三酸甘油酯、高胰島素分泌以及血液中痩素(丨eptj 濃度。 本發明係以簡單的製備方法所製成,且無需利用特殊 的$劑或繁複的萃取步驟即可達成,而且以本發明之方法 所萃取的紅雞屎藤萃取物經過多項測試後,可證明其具有HF (n = 37 · 〇 ± 1.38 soil 4.68 soil 0.599 soil 1.63 ± 5911 ± 1.8a 0.18a 0'21a 0.2a 0.45a 1623a hf + n 〇 · 11 (η 35.1 ± 1.14 soil 3.69 ± 0.462 ± 1.28 ± 4204 ± =6~7, 3.2b 0.32b 1,08b 0.2b 0_25a 2209b The values shown are the mean ± standard deviation value (SD). Statistical analysis 'P value (p_va|ue) < 〇〇 5 as a reference The superscripts a, b, and c represent significant differences. Table 5 shows that 'giving 1500 mg/kg body weight of red chicken vine vine alcoholic alcohol extract can significantly reduce high cholesterol, high triglyceride caused by high fat diet Ester, high insulin secretion and blood sputum (丨eptj concentration. The present invention is prepared by a simple preparation method, and can be achieved without using a special agent or a complicated extraction step, and is carried out by the method of the present invention. The extracted red chicken vine extract has been tested to prove that it has

調節血糖、血脂之功能,又可抑制糖解酵素和乙SI輔酶A 缓化酵素之活性,還可促進酿基輔酶a氧化酵素之活性, 因此能夠改善代謝症料,對於代謝症候群患者而 是—大福音。 0兄 乂上所述,僅是本發明的較佳實施例,並 :任::式上的限制,任何所屬技術領域中具有通常知識 右在不脫離本發明所提技術特徵的範 明所揭示技術内容所作出局部更動或修飾的等效=發It regulates the functions of blood sugar and blood lipids, and inhibits the activity of glycolytic enzymes and SI-CoA-lowering enzymes. It also promotes the activity of oxidizing enzymes of Kiev enzyme, thus improving metabolic syndrome. For patients with metabolic syndrome, Great gospel. The above description of the present invention is merely a preferred embodiment of the present invention, and is: a limitation on the formula, any technique having the general knowledge in the art, and not departing from the technical features of the present invention. Equivalent to the local change or modification of the content

2020

特徵的範圍内。 徵内容,均仍屬於本發 明技術 【圖式簡單說明】 第一圖係本發明的製備流程圖。 第二圖係本發明之紅雞屎藤酸性 辅酶A羧化酵素之活性的線性圖。 酒精萃取物抑制乙醯 第二(A)圖係利用不同劑量之氯苯丁酯促進醯基辅酶a 氧化酵素之活性的柱狀圖。 第二(B)圖係利用本發明1 〇〇/yg/m丨之紅雞屎藤酒精萃 取物促進酿基輔酶A氧化酵素之活性的柱狀圖。 【主要元件符號說明】 (a) 提供紅雞屎藤 (b) 萃取紅雞屎藤以獲取萃取物 (c) 濃縮乾燥萃取物 (d)獲取紅雞屎藤萃取物 (e)製備醫藥組合物 (f)製備食品組合物 21 < S >Within the scope of the feature. The content of the levy still belongs to the technology of the present invention. [Simplified description of the drawings] The first drawing is a flow chart of the preparation of the present invention. The second graph is a linear plot of the activity of the red cod vinegar acid coenzyme A carboxylase of the present invention. Alcohol Extract Inhibits Acetylene The second (A) diagram is a bar graph of the activity of different enzymes of chlorpheniramine to promote the activity of 醯K. The second (B) graph is a histogram for promoting the activity of the lytic enzyme A oxidase by using the 1 〇〇/yg/m丨 of the red cockroach vine alcohol extract of the present invention. [Explanation of main component symbols] (a) Providing red chicken vine (b) extracting red chicken vine to obtain extract (c) concentrating dry extract (d) obtaining red chicken vine extract (e) preparing pharmaceutical composition (f) preparing a food composition 21 < S >

Claims (1)

1331921 公告本^-- 十、申請專利範圍: 年沴詩日修正个1 1 一種紅雞屎藤萃取物,其製備步驟係包括: 提供新鮮或經乾燥之紅雞屎藤植株或局部; 以溶劑萃取該紅雞屎藤植株或局部以獲取溶劑萃取 物; 濃縮乾燥該溶劑萃取物;及 獲取紅雞屎藤萃取物, 其中該紅雞屎藤萃取物係用於改善代謝症候群。 2 .如申請專利範圍第1項所述之紅雞屎藤萃取物, 其中所提供之紅雞屎藤局部係根部與莖部。 3 ·如申凊專利範圍第2項所述之紅雞屎藤萃取物, 其中萃取§亥紅雞屎藤植株或局部的溶劑係選自於以下物質 所組成的群組.水 '醇類、醇類水溶液以及乙酸乙酿β 4 ·如申請專利範圍第3項所述之紅雞屎藤萃取物, 其中該溶劑為能與水混合成濃度在25~ 1 〇〇wt%的乙醇。 5 .如申請專利範圍第3項所述之紅雞屎藤萃取物, 其中該溶劑為能與水混合成濃度在7〇I 〇〇wt〇/0的乙醇。 6 ·如申凊專利範圍第3項所述之紅雞屎藤萃取物, 其中該乙醇進而含有鹽酸成為酸性酒精。 7.如申請專利範圍第6項所述之紅雞屎藤萃取物, 其中萃取該紅雞原藤莖部與根部係使用酸性酒精,在紅雞 屎藤重量與酸性酒精體積約為1:5至彳:20的比例範圍内, 於室溫下進行° 8 .如申請專利範圍第1至7項中任一項所述之紅雞 22 1331921 原藤萃取物’其中該改善代謝症,候群係 酵素、抑制肝臟乙醯輔酶A羧化酵素' 腸道糖解 氧化酵素、調節血糖濃度以及調節▲月旨滚声肝臟酿基辅酶A 9.一種用於改善代謝症候群的醫:: 括紅雞原藤萃取物及醫藥上可接受勿其係包 製備步驟包括: 竦形劑,其中 提供新鮮或經乾燥之紅雞屎藤植株或局邛. 物;以溶劑萃取該紅雞摩藤植株或局部:獲取溶劑萃取 濃縮乾燥該溶劑萃取物; 獲取紅雞屎藤萃取物;以及 將紅雞屎藤萃取物加入醫藥上 劑 以獲得醫藥組合物。 接又的载劑或職形 1 〇 .如申請專利範圍第9項所述之用於 候群的醫藥組合物,其中所提供之紅雞原藤局部虚 莖部。 ^ 11·如申請專利範圍帛10項所述之用於改善代謝 症候群的醫藥組合物,纟中在該紅㈣藤萃取物的製備步 驟中,該溶劑係選自於以下物質所組成的群組:水、醇類、 醇類水溶液以及乙酸乙g旨。 ! 2 . h申請專利範圍第工工項所述之用於改善代謝 症候群的㈣組合物,其中該溶劑為能與水混合成濃 25〜1 OOwt%的乙醇。 X 1 3 .如申請專利範圍第!工項所述之用於改善代謝 23 «31921 其中該溶劑為能與水混合成濃度在 症候群的醫藥組合物, 〜1 OOwt%的乙醇。 丄4 ·如甲睛專利筋圍笛η ^ ㈣第1 1項所述之用於改善代謝 症候群的醫藥組合物,a中哕Γ醢4 ^ 代潘 洒 、 '"乙醇進而含有鹽酸成為酸性 15 ·如f請專利範圍第14項所述之用於 症候群的醫藥組合物,其中 使用酸性酒精,在紅雞=雞原藤莖部與根部係 冑⑪料藤重置與酸性酒精體積約為1:5 至1.20的比例範圍内,於室溫下進行。 1 6 .如f請專利範圍第9&1 5項中任—項所述之 二:t善代謝症候群的醫藥組合物,"該改善代謝症候 群係包括抑騎道糖解料、抑制肝臟乙醯制A緩 ^、促進肝臟酿基辅酶A氧化酵素、調節血糖濃度以 郎灰脂濃度。 17·-帛適合代謝症候群病人的食品組合物…1331921 Announcement ^-- X. Application Patent Range: Amendment 1 1 A red chicken vine extract, the preparation steps include: providing fresh or dried red chicken vine plants or parts; Extracting or partially extracting the red pheasant plant to obtain a solvent extract; concentrating and drying the solvent extract; and obtaining an extract of the red carp, the vine extract, for improving metabolic syndrome. 2. The extract of the red pheasant vine as described in claim 1, wherein the root portion and the stem portion of the red pheasant are provided. 3. The extract of the red pheasant vine as described in claim 2, wherein the solvent extracted from the § 亥 红 屎 植 或 或 或 或 或 或 或 或 或 或 或 或 水 水 § § § § § § § § § § § § § § § § An aqueous solution of an alcohol and a beta acetate of the acetic acid according to claim 3, wherein the solvent is an ethanol which can be mixed with water to a concentration of 25 to 1% by weight. 5. The extract of Dioscorea opposita Thunb. according to claim 3, wherein the solvent is ethanol which can be mixed with water to a concentration of 7〇I 〇〇wt〇/0. [6] The red chicken vine extract according to claim 3, wherein the ethanol further contains hydrochloric acid to become an acidic alcohol. 7. The red chicken vine extract according to claim 6, wherein the raw vine stem and the root of the red hen are extracted with acidic alcohol, and the weight of the red pheasant and the acid alcohol is about 1:5. In the range of the ratio of 20: 20, the red chicken 22 1331921, the vine extract, as described in any one of claims 1 to 7, wherein the metabolic syndrome, the enzymes of the group are improved. Inhibition of Hepatic Acetyl Coenzyme A Carboxylase ' Intestinal Glycooxidase, Regulating Blood Glucose Concentration, and Regulating ▲ 旨 旨 肝脏 肝脏 肝脏 肝脏 肝脏 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. 9. And the pharmaceutically acceptable preparation step comprises: a scorpioning agent, wherein the fresh or dried red pheasant plant or the sorghum is provided; the red squid plant or part is extracted by solvent: obtaining the solvent The solvent extract is concentrated and dried by extraction; the extract of the red pheasant is obtained; and the extract of the red pheasant is added to the medicinal agent to obtain a pharmaceutical composition. Further, the carrier or the trait of the medicinal composition of the medicinal composition of claim 9, wherein the medicinal vine has a partial stalk portion. [11] The pharmaceutical composition for improving metabolic syndrome according to claim 10, wherein in the preparation step of the red (four) vine extract, the solvent is selected from the group consisting of the following substances; : water, alcohols, alcoholic aqueous solutions and acetic acid. 2. The composition of (4) for improving metabolic syndrome according to the above-mentioned application of the patent scope, wherein the solvent is ethanol which can be mixed with water to form a concentration of 25 to 100% by weight. X 1 3 . As claimed in the patent scope! The work described in the work for improving metabolism 23 «31921 wherein the solvent is a pharmaceutical composition capable of mixing with water to a concentration in the syndrome, ~100% by weight of ethanol.丄4 · For example, the medicinal composition for improving metabolic syndrome, as described in item 1 of item 1, a 哕Γ醢 4 ^ 代潘洒, '" ethanol and then hydrochloric acid becomes acidic 15 ·Please refer to the pharmaceutical composition for symptom group described in item 14 of the patent scope, in which acidic alcohol is used, and in the red chicken = chicken raw stem and root system, the vine is reset and the acid alcohol volume is about 1 : Within the ratio range of 5 to 1.20, it is carried out at room temperature. 1 6 . For example, please refer to the second part of the patent scope 9 &1 5 - the pharmaceutical composition of the metabolic syndrome, "the improved metabolic syndrome system includes inhibition of the sugar disintegration and inhibition of liver B Tanning A slows, promotes the liver to brew Kiev enzyme A oxidase, regulates the blood sugar concentration to lang ash fat concentration. 17·-帛 Food composition suitable for patients with metabolic syndrome... 括紅雞原藤萃取物,其製備步驟係包括:提供新鮮或二 燥之紅雞屎藤植株或局部; ’ l .以溶劑萃取該紅雞原藤植株或局部以獲取溶劑 ftm " 濃縮乾燥該溶劑萃取物; 獲取紅雞屎藤萃取物;以及 以作為改善代 將該紅雞屎藤萃取物製成食品組合物 謝症候群之用。Including the red chicken raw vine extract, the preparation step comprises: providing fresh or dry red pheasant plant or part; ' l. extracting the red hen original plant or part by solvent to obtain solvent ftm " concentrating and drying the solvent Extract; obtaining red chicken vine extract; and using the red chicken vine extract as a food additive for the Xie syndrome. 如申請專利範圍第1 7項所述之適合代謝症候 24 1331921 群病人的食品組合物,盆中所挥^ 與莖部。 /、中所“供之紅雞原藤局部係根部 1 9 · ”請專利範圍第1 8項所述之適合代 群病人的食品組合物’其中在該紅雞 謝症候 驟中,該溶劑係選自於以下物質所組.、 的製備步 醇類水溶液以及乙酸乙酯。 組·水、醇類、 20 ·如申請專利範圍第19項所述之 群病人的食品組合物,盆中哕、'交麵 π謝症候 m 合劑為能與水混合 25〜1 〇〇wt%的乙醇。 屣度在 21 ·如申請專利範圍第19項所述之適合 群病人的食品組合物,1中哕、.六逾 -症候 切其中該,合劑為能與水 70〜100wt%的乙醇。 场-農度在 22 .如申請專利範圍第19項所述之適合代 群病人的食品組合物,其中乙醇進 / 、 精。 而3有鹽…酸性酒 23 ·如中請專利範圍第22項所述之適合代謝症候 群病人的食品組合物’#中萃取該紅雞轉莖部與根部係 使用酸性酒精,在紅雞原藤重量與峻性酒精體積約為U 至1:20的比例範圍内,於室溫下進行。 24 .如中請專利範圍第17至23項中任_項所述 之適合代謝症候群病人的食品組合物,其中該改善代謝症 候群係包括抑制腸道糖解酵素、抑制肝臟A _ 酵素、促進肝義基制A氧化酵素、調節血糖濃度以及 調節血脂濃度。 25 1331921 Η—、囷式: 1331921A food composition suitable for a patient with metabolic syndrome 24 1331921 as described in claim 17 of the patent application, in which the stem is stalked. /, "The root part of the roots of the red hens of the red hens" is provided in the food composition of the group of patients as described in Item No. 18 of the patent range. In the red chicken Xie syndrome, the solvent is selected. Prepare an aqueous alcohol solution and ethyl acetate from the following materials. Group·Water, Alcohol, 20 · The food composition of the group of patients as described in claim 19 of the patent application, in the pot, the 'cross surface π Xie syndrome m mixture can be mixed with water 25~1 〇〇wt% Ethanol. The food composition of the group of patients as described in claim 19 of the patent application, in the middle of the sputum, the six-over-symptoms, wherein the mixture is 70-100% by weight of ethanol with water. The field-agronomy is 22. A food composition suitable for a group of patients as described in claim 19, wherein the ethanol is in/out of the essence. And 3 has salt...acid wine 23 ·If the food composition for the metabolic syndrome patients described in the 22nd item of the patent scope is extracted, the red chicken is used to extract the stem and the root system using acidic alcohol, and the weight of the red chicken is It is carried out at room temperature in a ratio ranging from about U to 1:20. 24. A food composition suitable for a metabolic syndrome patient according to any one of clauses 17 to 23, wherein the metabolic syndrome comprises inhibiting intestinal glycolytic enzyme, inhibiting liver A_enzyme, and promoting liver A system of A-oxidase, regulate blood sugar concentration and regulate blood lipid concentration. 25 1331921 Η—, 囷: 1331921 第一圖First picture 1201331921 抑制ACC活性的程度(%) 100 80 60 40 20 01201331921 Degree of inhibition of ACC activity (%) 100 80 60 40 20 0 0.001 0.01 0.1 1 10 紅雞屎藤酸性酒精萃取物的濃度(mg/m 1) 第二圖 1331921 (B) AC0活性增加的倍數 ο 5 4 3 20.001 0.01 0.1 1 10 Concentration of acid alcohol extract of red pheasant (mg/m 1) Second figure 1331921 (B) Multiple of AC0 activity increase ο 5 4 3 2 ACO活性增加的倍數 4S hr. 72 hr. 3 2Multiples of increased ACO activity 4S hr. 72 hr. 3 2 48 hr 時間 時間 第三圖48 hr time time third picture
TW96144911A 2007-08-03 2007-11-27 Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof TW200906431A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TW96144911A TW200906431A (en) 2007-08-03 2007-11-27 Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof
JP2008183769A JP5156515B2 (en) 2007-08-03 2008-07-15 A composition for improving metabolic syndrome, comprising an extract of Taiwan mulberryflorum humb. ExMurrayvar.
US13/098,142 US8273388B2 (en) 2007-08-03 2011-04-29 Extract of Polygonum multiflorum Thunb. ex Murray var. hypoleucum and compositions for improving metabolic syndrome

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW96128525 2007-08-03
TW96144911A TW200906431A (en) 2007-08-03 2007-11-27 Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof

Publications (2)

Publication Number Publication Date
TW200906431A TW200906431A (en) 2009-02-16
TWI331921B true TWI331921B (en) 2010-10-21

Family

ID=44723142

Family Applications (1)

Application Number Title Priority Date Filing Date
TW96144911A TW200906431A (en) 2007-08-03 2007-11-27 Polygonum multiflorum extract capable of improving metabolic syndrome, pharmaceutical and food compositions thereof

Country Status (1)

Country Link
TW (1) TW200906431A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102604803A (en) * 2012-03-28 2012-07-25 钟定良 Preparation method for ginseng-polygonum multiflorum nourishing solution

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102604803A (en) * 2012-03-28 2012-07-25 钟定良 Preparation method for ginseng-polygonum multiflorum nourishing solution

Also Published As

Publication number Publication date
TW200906431A (en) 2009-02-16

Similar Documents

Publication Publication Date Title
Tian et al. Anti-diabetic effect of methylswertianin and bellidifolin from Swertia punicea Hemsl. and its potential mechanism
Lo et al. Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin
RU2700793C2 (en) Pharmaceutical composition containing silybin, vitamin e and l-carnitine
CN101474313B (en) Application of theabrownin in pharmacy
TW201618801A (en) Pharmaceutical composition used for assisting chemotherapy drug and application thereof
CN101332230A (en) Prunella plant extract, preparation method and use thereof
CN106902129B (en) Application of active ingredients of Trillium medicinal material in preparation of liver protecting or liver protecting medicine
EP2120924B1 (en) An anti-diabetic extract of honeybush
Chewchinda et al. Antidiabetic effects of Maclura cochinchinensis (Lour.) corner heartwood extract
TWI331921B (en)
CN103766901A (en) Application of andrographolide C to preparation of weight-losing food or medicine
JP3628999B2 (en) Anonymous tea and its manufacturing method
CN106962910B (en) Health-care composition for reducing blood pressure
CN105012826A (en) Alpinia oxyphylla leaf extract and preparation method and application thereof
CN104800298A (en) Traditional Chinese medicine granular preparation for treating gout and preparation method thereof
JP2009137920A (en) Glycogen phosphorylase inhibitor
JP2009203209A (en) Composition for blood sugar reduction and/or anti-obesity containing material originated from bark of acacia
US8273388B2 (en) Extract of Polygonum multiflorum Thunb. ex Murray var. hypoleucum and compositions for improving metabolic syndrome
WO2013138964A1 (en) Application of iso-daphnetin compound in preparation of anti-diabetic medicines
JPH09241157A (en) Medicinal composition for protecting liver containing lithospermate b
CN100453073C (en) Compound radical lobelia dripping pill and its preparing method
US20110195135A1 (en) Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent
JP4636475B2 (en) Antidiabetic
JP5156515B2 (en) A composition for improving metabolic syndrome, comprising an extract of Taiwan mulberryflorum humb. ExMurrayvar.
TWI387461B (en) Use of overground part of hedychium coronarium koenig in reducing blood glucose; extracts and compositions of overground part of hedychium coronarium koenig and their uses